These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20439526)

  • 21. Tocilizumab versus adalimumab for rheumatoid arthritis.
    De Vita S
    Lancet; 2013 May; 381(9877):1515-7. PubMed ID: 23642688
    [No Abstract]   [Full Text] [Related]  

  • 22. Comment on "Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks" by Yokoe et al.
    Nagashima T; Okazaki H; Kamata Y; Minota S
    Mod Rheumatol; 2012 Aug; 22(4):638-9; authoe reply 640-2. PubMed ID: 22669601
    [No Abstract]   [Full Text] [Related]  

  • 23. Tocilizumab versus adalimumab for rheumatoid arthritis - Authors' reply.
    Gabay C; Kavanaugh A;
    Lancet; 2013 Aug; 382(9890):395. PubMed ID: 23911377
    [No Abstract]   [Full Text] [Related]  

  • 24. Tocilizumab treatment in a patient suffering from rheumatoid arthritis and concomitant chronic hepatitis C infection.
    Dragonas C; Ehrenstein B; Fleck M
    Rheumatology (Oxford); 2012 Aug; 51(8):1520-1. PubMed ID: 22467085
    [No Abstract]   [Full Text] [Related]  

  • 25. [Rheumatoid arthritis and ankylosing spondylitis-rheumatologic highlights 2009].
    Dudler J
    Rev Med Suisse; 2010 Jan; 6(232):141-2, 144. PubMed ID: 20170034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New treatments for rheumatoid arthritis].
    Girault V; Flipo RM
    Soins; 2004 Sep; (688):37-8. PubMed ID: 15515847
    [No Abstract]   [Full Text] [Related]  

  • 27. Simultaneous pulmonary involvement, histologically proven, of sarcoidosis and rheumatoid arthritis.
    Leo G; Iuliano A; Spina D; Bellisai F; Fioravanti A; Galeazzi M
    Clin Exp Rheumatol; 2009; 27(1):164. PubMed ID: 19327247
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment, management, and monitoring of established rheumatoid arthritis.
    Bingham CO; Miner MM
    J Fam Pract; 2007 Oct; 56(10 Suppl Rapid):S1-7; quiz S8. PubMed ID: 17949607
    [No Abstract]   [Full Text] [Related]  

  • 29. Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.
    Baltà-Cruz S; Alsina-Glbert M; Mozos-Rocafort A; Cervera C; Colomo-Saperas L; Del Río A; Estrach-Panella T
    Acta Derm Venereol; 2009; 89(4):432-3. PubMed ID: 19688168
    [No Abstract]   [Full Text] [Related]  

  • 30. Adalimumab for rheumatoid arthritis?
    Ebell M; Kripke C
    Am Fam Physician; 2006 Feb; 73(3):435-6. PubMed ID: 16479667
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of etanercept plus lamivudine in a patient with rheumatoid arthritis and viral hepatitis B.
    Benucci M; Manfredi M; Mecocci L
    J Clin Rheumatol; 2008 Aug; 14(4):245-6. PubMed ID: 18766129
    [No Abstract]   [Full Text] [Related]  

  • 32. Biologic agents for rheumatoid arthritis: 2008 and beyond.
    Sweiss NJ; Hushaw LL
    J Infus Nurs; 2009; 32(1 Suppl):S4-17; quiz S19-24. PubMed ID: 19142153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term course of chronic hepatitis B and C under treatment with etanercept associated with different disease modifying antirheumatic drugs without antiviral prophylaxis.
    Cansu DU; Kalifoglu T; Korkmaz C
    J Rheumatol; 2008 Mar; 35(3):421-4. PubMed ID: 18203328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of adalimumab in treatment of autoimmune sensorineural hearing loss: a word of caution.
    Conway R; Khan S; Foley-Nolan D
    J Rheumatol; 2011 Jan; 38(1):176; author reply 176. PubMed ID: 21196585
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical trials. Gene transfer an unlikely contributor to patient's death.
    Kaiser J
    Science; 2007 Dec; 318(5856):1535. PubMed ID: 18063761
    [No Abstract]   [Full Text] [Related]  

  • 36. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
    Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
    J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rheumatology 2010].
    Hermann W; Müller-Ladner U
    Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1309-11. PubMed ID: 20556688
    [No Abstract]   [Full Text] [Related]  

  • 38. [Adalimumab slows the progression of rheumatoid arthritis].
    Pharm Unserer Zeit; 2003; 32(1):75-6. PubMed ID: 12577764
    [No Abstract]   [Full Text] [Related]  

  • 39. Recombinant DNA product for rheumatoid arthritis.
    FDA Consum; 2003; 37(2):5. PubMed ID: 12715755
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adalimumab in advanced and early rheumatoid arthritis].
    Szekanecz Z
    Orv Hetil; 2009 Jul; 150(28):1333-4. PubMed ID: 19581162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.